Milestone Pharmaceuticals Correlations

MIST Stock

USD 1.84 0.01 0.54%

The current 90-days correlation between Milestone Pharmaceuticals and DiaMedica Therapeutics is 0.02 (i.e., Significant diversification). The correlation of Milestone Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.

Milestone Pharmaceuticals Correlation With Market

Very weak diversification

The correlation between Milestone Pharmaceuticals and DJI is 0.42 (i.e., Very weak diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Milestone Pharmaceuticals and DJI in the same portfolio, assuming nothing else is changed.

Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Milestone Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.

For more information on how to buy Milestone Stock please use our How to Invest in Milestone Pharmaceuticals guide.

Moving together with Milestone Stock

0.69	BMY	Bristol Myers Squibb Aggressive Push	Pair Corr
0.7	GILD	Gilead Sciences	Pair Corr
0.8	MDGL	Madrigal Pharmaceuticals	Pair Corr
0.67	RNXT	RenovoRx	Pair Corr

Moving against Milestone Stock

0.78	JNJ	Johnson Johnson Sell-off Trend	Pair Corr
0.75	LLY	Eli Lilly Sell-off Trend	Pair Corr
0.74	PFE	Pfizer Inc Aggressive Push	Pair Corr
0.73	INZY	Inozyme Pharma	Pair Corr
0.65	VALN	Valneva SE ADR	Pair Corr
0.65	LEGN	Legend Biotech Corp	Pair Corr
0.64	MRK	Merck Company Fiscal Year End 6th of February 2025	Pair Corr
0.6	EQ	Equillium	Pair Corr
0.57	ME	23Andme Holding	Pair Corr
0.53	GMAB	Genmab AS	Pair Corr
0.48	CINGW	Cingulate Warrants	Pair Corr
0.43	IPSC	Century Therapeutics	Pair Corr
0.36	A	Agilent Technologies Earnings Call Today	Pair Corr
0.57	NKTX	Nkarta Inc	Pair Corr
0.57	PHAT	Phathom Pharmaceuticals	Pair Corr
0.56	ABBV	AbbVie Inc	Pair Corr
0.54	MTEM	Molecular Templates	Pair Corr
0.54	AMGN	Amgen Inc	Pair Corr
0.41	LYRA	Lyra Therapeutics	Pair Corr
0.37	MDWD	Mediwound	Pair Corr

Related Correlations Analysis

	DMAC	MCRB	IKT	ONCY	SCPH	LIFE	XFOR	GRTX	TERN	DAWN
DMAC		-0.1	0.24	0.48	-0.32	-0.31	-0.34	0.24	-0.06	0.17	DMAC
MCRB	-0.1		-0.65	-0.43	0.72	0.15	0.69	0.53	0.85	-0.12	MCRB
IKT	0.24	-0.65		0.5	-0.55	-0.04	-0.57	-0.4	-0.66	0.63	IKT
ONCY	0.48	-0.43	0.5		-0.38	0.0	-0.47	0.11	-0.41	0.33	ONCY
SCPH	-0.32	0.72	-0.55	-0.38		0.37	0.86	0.27	0.74	-0.04	SCPH
LIFE	-0.31	0.15	-0.04	0.0	0.37		0.32	0.22	0.27	0.16	LIFE
XFOR	-0.34	0.69	-0.57	-0.47	0.86	0.32		0.27	0.76	0.05	XFOR
GRTX	0.24	0.53	-0.4	0.11	0.27	0.22	0.27		0.57	0.1	GRTX
TERN	-0.06	0.85	-0.66	-0.41	0.74	0.27	0.76	0.57		-0.05	TERN
DAWN	0.17	-0.12	0.63	0.33	-0.04	0.16	0.05	0.1	-0.05		DAWN
	DMAC	MCRB	IKT	ONCY	SCPH	LIFE	XFOR	GRTX	TERN	DAWN

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Please upgrade your account to get full access to Macroaxis premium features

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

XFOR	+ 0.86	SCPH
TERN	+ 0.85	MCRB
TERN	+ 0.76	XFOR
TERN	+ 0.74	SCPH
SCPH	+ 0.72	MCRB
XFOR	+ 0.69	MCRB

High negative correlations

TERN	- 0.66	IKT
IKT	- 0.65	MCRB
XFOR	- 0.57	IKT
SCPH	- 0.55	IKT
XFOR	- 0.47	ONCY
ONCY	- 0.43	MCRB

Risk-Adjusted Indicators

There is a big difference between Milestone Stock performing well and Milestone Pharmaceuticals Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Milestone Pharmaceuticals' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
DMAC	2.31	0.28	0.07	4.62	2.11	(2.67)	4.94	(3.29)	10.25
MCRB	4.68	0.01	(0.02)	0.25	5.68	(5.36)	10.00	(9.78)	28.84
IKT	4.59	0.76	0.16	0.51	4.82	(5.41)	13.45	(9.09)	37.40
ONCY	3.50	0.19	0.00	(0.24)	3.52	(4.95)	7.83	(6.67)	36.56
SCPH	2.68	(0.82)	0.00	(0.32)	0.00	0.00	4.30	(7.09)	20.70
LIFE	2.57	0.46	0.09	(0.82)	2.62	(3.23)	6.45	(5.29)	28.98
XFOR	4.97	(0.84)	0.00	(0.45)	0.00	0.00	6.90	(10.61)	62.35
GRTX	2.93	0.05	0.00	0.04	0.00	0.00	7.31	(5.84)	18.16
TERN	3.37	(0.50)	0.00	(0.29)	0.00	0.00	5.68	(5.96)	34.09
DAWN	2.10	(0.08)	(0.03)	0.03	2.72	(2.01)	3.84	(3.69)	11.44

Milestone Pharmaceuticals Corporate Management

Anita Holz	VP Affairs	Profile
Guy Rousseau	SVP Management	Profile
FACC FAHA	Chief Board	Profile
Jeffrey Nelson	Chief Officer	Profile
Roshan Girglani	Vice Marketing	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC